Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 154,904 | 144,285 | 127,044 | 107,672 | 86,346 |
| Cost of Goods | 41,347 | 38,648 | 65,105 | 54,874 | 46,021 |
| Gross Profit | 113,557 | 105,637 | 61,939 | 52,798 | 40,325 |
| Operating Expenses | 116,442 | 117,813 | 172,659 | 228,330 | 258,174 |
| Operating Income | -2,538 | -11,528 | -110,615 | -174,658 | -217,828 |
| Interest Expense | 9,605 | 6,032 | 3,868 | 2,474 | 2,410 |
| Other Income | -8,052 | 3,980 | 3,924 | -4,892 | -445 |
| Pre-tax Income | -20,195 | -13,580 | -110,559 | -182,024 | -220,683 |
| Net Income Continuous | -20,195 | -13,580 | -110,559 | -182,024 | -220,683 |
| Net Income | $-20,195 | $-13,580 | $-110,559 | $-182,024 | $-220,683 |
| EPS Basic Total Ops | -0.12 | -0.09 | -0.80 | -1.67 | -2.24 |
| EPS Basic Continuous Ops | -0.12 | -0.09 | -0.80 | -1.67 | -2.24 |
| EPS Diluted Total Ops | -0.12 | -0.09 | -0.80 | -1.67 | -2.24 |
| EPS Diluted Continuous Ops | -0.12 | -0.09 | -0.80 | -1.67 | -2.24 |
| EPS Diluted Before Non-Recurring Items | -0.07 | -0.09 | -0.80 | -1.67 | -2.24 |
| EBITDA(a) | $-146 | $-10,218 | $-109,116 | $-172,303 | $-213,571 |